ArticleiScience2025

Targeting Cdc42 improves motor phenotype in Parkinson's disease mice and reveals age-dependent susceptibility to α-synuclein.

Verena Bopp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.